Company Metrics

• 1.05 P/E
• 0.2 P/S
• 0.13 P/B
• -2.223 EPS
• 11.18% Cash ROIC
• 2.55 Cash Ratio
• 0 / 0% Dividend
• 21,739.00 Avg. Vol.
• 11.65M Shares
• 9.2M Market Cap.

Company Description

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products, and health supplement products for various diseases and conditions in the People's Republic of China. Its primary product includes the Xin Ao Xing Oleanolic Acid Capsule, an OTC medicine for the treatment of chronic hepatitis B. The company's products also include Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat pain, headache, and fever; and Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for the treatment of pain and other symptoms associated with menstruation. Its prescription pharmaceutical products comprise Danshen granule for the treatment of coronary heart disease, myocarditis, and angina pectoris; and Taohuasan pediatric medicine for the treatment of bronchial congestion and coughs in children. The company also manufactures hernia belt; and five health supplements. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of dedicated sales people in approximately 22 provinces. The company was founded in 1995 and is headquartered in Xianyang, the People's Republic of China.
less

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products, and health supplement products for various diseases and conditions in the People's Republic of China. Its primary product includes the Xin Ao Xing Oleanolic Acid Capsule, an OTC medicine for the treatment of chronic hepatitis B. The company's products also include Ganw...
more

News